Completed NA INTERVENTIONAL 2-arm NCT03348007

Clinical Trial Assessing the Efficacy and Safety of Hépar® in Chronic Constipation (HEP02)

A Randomized Double-blind Placebo-controlled Clinical Trial Assessing the Efficacy and Safety of Hépar® in Chronic Constipation

Sponsor: Quanta Medical

Conditions Constipation - Functional

Interventions Taking two kinds of mineral water

Updated 5 times since 2017 Last updated: Nov 22, 2017 Started: Jan 30, 2015 Primary completion: Jul 22, 2016 Completion: Jul 22, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Constipation - Functional, this trial is completed. The trial is conducted by Quanta Medical and has accumulated 5 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Dec 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Quanta Medical

Data source: Quanta Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rueil-Malmaison, France